4,963
Views
23
CrossRef citations to date
0
Altmetric
Research Paper

Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension

, , , , , , , , , , , , , , & show all
Pages 5173-5183 | Received 05 May 2021, Accepted 01 Jul 2021, Published online: 18 Aug 2021

References

  • Thenappan T, Khoruts A, Chen Y, et al. Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension? Am J Physiol Heart Circ Physiol. 2019;317:H1093–H1101.
  • Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1):1801887.
  • Smith KA, Ayon RJ, Tang H, et al. Calcium-sensing receptor regulates cytosolic [Ca (2+)] and plays a major role in the development of pulmonary hypertension. Front Physiol. 2016;7:517.
  • Tang H, Yamamura A, Yamamura H, et al. Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2016;310:L846–859.
  • Yamamura A, Guo Q, Yamamura H, et al. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension. Circ Res. 2012;111:469–481.
  • Dumas A, Bernard L, Poquet Y, et al. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cell Microbiol. 2018;20:e12966.
  • Vaughan A, Frazer ZA, Hansbro PM, et al. COPD and the gut-lung axis: the therapeutic potential of fibre. J Thorac Dis. 2019;11:S2173–S2180.
  • Wedgwood S, Warford C, Agvatisiri SR, et al. The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model. Pediatr Res. 2020;87:472–479.
  • Nagpal R, Yadav H. Bacterial translocation from the gut to the distant organs: an overview. Ann Nutr Metab. 2017;71(Suppl 1):11–16.
  • Takiishi T, Fenero CIM, Camara NOS. Intestinal barrier and gut microbiota: shaping our immune responses throughout life. Tissue Barriers. 2017;5:e1373208.
  • Pascale A, Marchesi N, Marelli C, et al. Microbiota and metabolic diseases. Endocrine. 2018;61:357–371.
  • Callejo M, Mondejar-Parreno G, Barreira B, et al. Pulmonary arterial hypertension affects the rat gut microbiome. Sci Rep. 2018;8:9681.
  • Sanada TJ, Hosomi K, Shoji H, et al. Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model. Pulm Circ. 2020;10:2045894020929147.
  • Kim S, Rigatto K, Gazzana MB, et al. Altered gut microbiome profile in patients with pulmonary arterial hypertension. Hypertension. 2020;75:1063–1071.
  • Zhao YY, Lin RC. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chem Biol Interact. 2014;215:7–16.
  • Su G, Wang H, Bai J, et al. A metabonomics approach to drug toxicology in liver disease and its application in traditional Chinese medicine. Curr Drug Metab. 2019;20:292–300.
  • Niu JL, Zhang J, Wei LQ, et al. Effect of fermented cottonseed meal on the lipid-related indices and serum metabolic profiles in broiler chickens. Animals (Basel). 2019;9 (11):930.
  • Li H, He Z, Gao D, et al. Characteristics of the intestinal microbiota in very low birth weight infants with extrauterine growth restriction. Front Pediatr. 2019;7:99.
  • Niu J, Zhang J, Wei L, et al. Cottonseed meal fermented by candida tropical reduces the fat deposition in white-feather broilers through cecum bacteria-host metabolic cross-talk. Appl Microbiol Biotechnol. 2020;104:4345–4357.
  • Duan Y, Xiong D, Wang Y, et al. Toxic effects of ammonia and thermal stress on the intestinal microbiota and transcriptomic and metabolomic responses of litopenaeus vannamei. Sci Total Environ. 2021;754:141867.
  • Yang J, Yang Y, Ishii M, et al. Does the gut microbiota modulate host physiology through polymicrobial biofilms? Microbes Environ. 2020;35 (3):ME20037.
  • Zhang Y, Wang Y, Ke B, et al. TMAO: how gut microbiota contributes to heart failure. Transl Res. 2021;228:109–125.
  • Das B, Nair GB. Homeostasis and dysbiosis of the gut microbiome in health and disease. J Biosci. 2019;44(5):117.
  • Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216:20–40.
  • Quaranta G, Sanguinetti M, Masucci L. Fecal microbiota transplantation: a potential tool for treatment of human female reproductive tract diseases. Front Immunol. 2019;10:2653.
  • Chung HJ, Sim JH, Min TS, et al. Metabolomics and lipidomics approaches in the science of probiotics: a review. J Med Food. 2018;21:1086–1095.
  • Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15:55–63.